Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Nvidia Shares Propel Maverick in the First Half
Stephen Taub
July 20, 2023
Premium
Biopharma Funds Continue to Disappoint
Stephen Taub
July 18, 2023
Premium
Discovery Leads Macro Funds
Stephen Taub
July 18, 2023
Premium
Credit Funds Add to Their Gains
Stephen Taub
July 17, 2023
Premium
Skye Continues to Soar
Stephen Taub
July 13, 2023
Premium
Light Street, Lone Pine Lead the Tigers
Stephen Taub
July 12, 2023
Premium
Third Point Posts Modest June Gain
Stephen Taub
July 10, 2023
Premium
Haidar Surged 27% in June
Stephen Taub
July 10, 2023
Premium
Suvretta’s Prescription for Growth
Stephen Taub
July 6, 2023
Premium
Hedge Fund Favorites Continue to Beat the Market
Stephen Taub
July 5, 2023
Premium
Greenlight Surges in June
Stephen Taub
July 3, 2023
Premium
At Hedge Funds, Private Market Investments Continue to Languish
Stephen Taub
June 29, 2023
Premium
Hedge Funds Miss the Boat
Stephen Taub
June 28, 2023
Premium
Hedge Funds Eye Biopharma IPO
Stephen Taub
June 27, 2023
Premium
Sosin Partners Goes Activist
Stephen Taub
June 26, 2023
Premium
Biopharma M&A Finally Seems To Be Waking Up
Stephen Taub
June 22, 2023
Premium
For Viking, Slow and Steady Wins the Race
Stephen Taub
June 21, 2023
Premium
Gabe Plotkin’s Next Act
Stephen Taub
June 20, 2023
More Articles